Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder:A Three-Month Observational Study

被引:10
|
作者
Lee, Min Soo [2 ]
Yum, Sun Young [1 ]
Hong, Jin Pyo [3 ]
Yoon, Se Chang [4 ]
Noh, Jai Sung [5 ]
Lee, Kwang Hun [6 ]
Kim, Jung Ki [7 ]
Lee, Sang Yeol [8 ]
Singh, Pritibha [9 ]
Treuer, Tamas [10 ]
Reed, Victoria [9 ]
Raskin, Joel [11 ]
机构
[1] Eli Lilly & Co, Seoul, South Korea
[2] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea
[3] Univ Ulsan, Asan Med Ctr, Dept Psychiat, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neuropsychiat, Seoul, South Korea
[5] Ajou Univ, Sch Med, Dept Psychiat, Suwon 441749, South Korea
[6] Donguk Univ, Kyoungju Med Ctr, Dept Neuropsychiat, Gyeongju, South Korea
[7] Pusan Merinol Med Ctr, Dept Neuropsychiat, Pusan, South Korea
[8] Wonkwang Univ Hosp, Dept Psychiat, Iksan, South Korea
[9] Eli Lilly & Co, Intercontinental Informat Sci, Sydney, NSW, Australia
[10] Eli Lilly & Co, Budapest, Hungary
[11] Eli Lilly & Co, Lilly Res Labs, Toronto, ON, Canada
关键词
Pain; Depressive disorder; Major; Korea; Quality of life; Depression; Culture; TENSION-TYPE HEADACHE; PSYCHIATRIC-DISORDERS; SOMATIC SYMPTOMS; IMMIGRANT WOMEN; HWA-BYUNG; AMERICAN; EPIDEMIOLOGY; SOMATIZATION; PREVALENCE; DULOXETINE;
D O I
10.4306/pi.2009.6.4.255
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective This paper aims to examine the association between painful physical symptoms (ITS) and major depressive disorder (MDD) in a naturalistic clinical practice setting within a Korean population. Methods Patients with acute MDD that joined a multicountry, observational, three-month Study in six Asian countries and regions ere classified as PPS+ (mean score >= 2) and PPS- (mean score <2) using the modified Somatic Symptom Inventory. In this analysis, we report, the results from the Korea,, subset, where depression severity was assessed using the Clinical Global Impression of Severity (CGI-S) scale and 17-item Hamilton Depression Rating Scale (HAMD(17)) Pain severity was measured using a Visual analogue scale (VAS), while the EuroQoL (EQ-5D) assessed patient well-being. Results Of 198 patients, 45.96% (91/198) of patients were classified as PPS+ of which, 78.02% (71/91) were women. PPS+ patients had significantly more severe depression at baseline {CGI-S score, mean [standard deviation (SD)], PPS+: 5.09 [0.79]; PPS-: 4.63 [0.76]; p<0.001; HAMD(17) total score, mean [SD], PPS+: 24.34 [5.24]; PPS-: 20.76 [5.12]; p<0.001} and poorer quality of life [EQ-5D overall health state, mean (SD), PPS+: 39.37 (20.52); PPS-: 51.27 [20.78]; p<0.001] than PPS- patients. Both groups improved significantly (p<0.001) in depression and pain severity outcomes, as well as quality of life by end-point, but 110 significant within-group baseline-to-endpoint change wase observed. Conclusion The frequency of PPS was common in Korean patients with MDD and was, associated with more severe depression, poorer quality of life, and a trend towards poorer clinical outcome. Psychiatry Invest 2009;6:255-263
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [31] Prevalence and association of somatic symptoms in patients with Major Depressive Disorder
    Vaccarino, Anthony L.
    Sills, Terrence L.
    Evans, Kenneth R.
    Kalali, Amir H.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 110 (03) : 270 - 276
  • [32] Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
    Harada, Eiji
    Satoi, Yoichi
    Kikuchi, Toshiaki
    Watanabe, Koichiro
    Alev, Levent
    Mimura, Masaru
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1599 - 1607
  • [33] Frequency and outcomes of painful physical symptoms in a naturalistic population with major depressive disorder: an analysis of pooled observational studies focusing on subjects aged 65 years and over
    Brnabic, A.
    Raskin, J.
    Alev, L.
    Monkul, E. Serap
    Lowry, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (12) : 1158 - 1167
  • [34] Clinical features and treatment outcomes of major depressive disorder with genital symptoms
    Wu, Xiaohui
    Zhu, Yuncheng
    Sun, Ping
    Wang, Shuo
    Wu, Zhiguo
    Huang, Jia
    Cao, Lan
    Wang, Yun
    Su, Yousong
    Yao, Zhijian
    Wang, Zuowei
    Wang, Fan
    Wang, Yong
    Peng, Daihui
    Chen, Jun
    Fang, Yiru
    CHINESE MEDICAL JOURNAL, 2024, 137 (05) : 622 - 624
  • [35] Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
    Haider, Miqdad
    Shafqat, Muhammad Nabeel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2505 - 2506
  • [36] Clinical features and treatment outcomes of major depressive disorder with genital symptoms
    Wu Xiaohui
    Zhu Yuncheng
    Sun Ping
    Wang Shuo
    Wu Zhiguo
    Huang Jia
    Cao Lan
    Wang Yun
    Su Yousong
    Yao Zhijian
    Wang Zuowei
    Wang Fan
    Wang Yong
    Peng Daihui
    Chen Jun
    Fang Yiru
    中华医学杂志英文版, 2024, 137 (05)
  • [37] Correlation between White Matter Changes and Clinical Symptoms in Patients with Major Depressive Disorder
    Zhao, Fei Fei
    Jin, Yi Chang
    Chen, Xin Liang
    NEUROCHEMICAL JOURNAL, 2024, 18 (02) : 362 - 371
  • [38] Association between inflammatory cytokines and symptoms of major depressive disorder in adults
    Min, Xue
    Wang, Genwei
    Cui, Yalian
    Meng, Peipei
    Hu, Xiaodong
    Liu, Sha
    Wang, Yanfang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [39] Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
    Novick, Diego
    Montgomery, William
    Vorstenbosch, Ellen
    Victoria Moneta, Maria
    Duenas, Hector
    Maria Haro, Josep
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1859 - 1868
  • [40] Association between cognitive symptoms and everyday functioning in patients with major depressive disorder (MDD) in routine clinical practice in Greece
    Galanopoulos, A.
    Roukas, D.
    Karaiskos, D.
    Argyropoulos, I.
    Spyropoulou, A.
    Vassilopoulou, P.
    Fotiadis, P.
    Papalexi, E.
    EUROPEAN PSYCHIATRY, 2019, 56 : S88 - S88